Health research opportunities in FP6

Download Report

Transcript Health research opportunities in FP6

EU-funded health research activities
against TB: FP6 actions and
perspectives toward FP7
DG Research - European Commission
22 MARCH 2007
1
FP6 Tools and Instruments
Strategy for Poverty Related Diseases (PRD)
Project funding:focus on product development pipeline

Large consortia: basic and preclinical research up to early
human testing (10 M€ / 10+ partners / 5 y) Number of TB
Projects: 3

Small-scale, high risk projects (1-2 M€ / 2-3 years / young
researchers/ SMEs) Number of TB Projects: 19
Programme funding: EDCTP
2

Focus on phase II-III clinical trials

Coordination of national research programmes on PRDs

Independent legal entity
Overall Research Strategy
of the 6th Framework Programme to confront
HIV/AIDS, Malaria and Tuberculosis
EUROPEAN DEVELOPING COUNTRIES
CLINICAL TRIALS PARTNERSHIP (EDCTP)
HIV/AIDS
Malaria
Clinical Trials
(Phase II/III)
TB
SOME STRUCTURING CAs, SSAs ?
Early human
testing
NEW INSTRUMENTS
• Vaccines (NoE)
• Microbicides (IP)
•Drugs (IP)
• Vaccines (IP/NoE)
• Therapy Trials in Europe •Biology and
Pathology (NoE)
Pre-clinical
•Vaccines (IP)
•Drugs (IP)
CROSS-CUTTING TOPICS:
Mucosal vaccines for PRD (IP)
Neonatal vaccination strategies for PRD
3
HIGH RISK PROJECTS (STREPS)
DEFINED SUPPORTING ACTIVITIES (SSA)
Discovery
Genomics
Distribution of EC funding to
PRD during FP6 (2002-2006)
Discovery
Translational
research
87 M€
(19%)
Clinical (incl.
EDCTP)
134 M€
237 M€
(29%)
(52%)
Disease distribution
(EDCTP not included)
Total
(%)
458 M€
(100%)
Product distribution
(EDCTP not included)
Diagnost
3%
TB
24%
Vaccines
43%
Malaria
25%
TB funding: 61 M€
4
HIV/AIDS
51%
Treatm.
48%
Microbici
6%
FP7 2007 –2013
Specific Programmes
Cooperation – Collaborative research
Ideas – Frontier Research
People – Marie Curie Actions
Capacities – Research Capacity
5
Cooperation:
Collaborative research in FP7
Thematic Priorities
1.
2.
3.
4.
Health
Food, agriculture, fisheries and biotechnology
Information and communication technologies
Nanosciences, nanotechnologies, materials
and new production technologies
5. Energy
6. Environment (including climate change)
7. Transport (including aeronautics)
8. Socio-economic sciences and the humanities
9. Security
10. Space
6
Collaborative research
in the Health theme
Main policy drivers:
 Improving health of European citizens
 Increasing competitiveness of European healthrelated industries and businesses
 Addressing European and global health issues,
including emerging epidemics
• Budget:
 €6.1 billion over 7 years (2007-2013)
7
First calls of FP7
 1st FP7 workprogramme: 22 Dec 2006
 Deadline 1: 19 April 2007
 Deadline 2: 18 September 2007
8
Infectious Diseases:
Continuity of Challenges in
FP7
Longer duration - larger budget
Continuity from FP6 (pipeline approach)
• Focus on product development
• Focus on collaborative research
• Focus on global health problems
Create Partnerships
• Between scientists from different disciplines
• Between scientists from different countries
• Between different sectors: Industry-academia
9
Topics from first calls
Health
HIV/AIDS, malaria and tuberculosis (1)
Topics for first call (19 April 2007):
• Highly innovative approaches for research into host-pathogen
interaction in tuberculosis (FRP).
• Development of fast tests for the diagnosis of Multi-Drug-Resistant
strains of HIV, malaria and tuberculosis and of latent tuberculosis
infection (LTBI) (FRP).
• Paediatric formulations of drugs against HIV/AIDS, malaria and
tuberculosis (CA or SA).
10
Topics from first calls
Health
HIV/AIDS, malaria and tuberculosis (2)
Topics for second call (18 September 2007):
•European network for study and clinical management of TB drug
resistance (IP)
SICA topics for second call (18 September 2007):
• Highly innovative research in HIV/AIDS, malaria and tuberculosis
between Indian and European partners.
Targeted Region: India. Other ICPCs are also encouraged to join (FRP).
• Coordination of European research activities with global initiatives,
including Public-Private Partnerships.
Targeted Regions: ICPC (CA or SA).
• Next generation of researchers for HIV/AIDS, malaria, tuberculosis
and neglected infectious diseases.
Targeted Regions: ICPC (CA or SA).
11
Information &
useful addresses
•National Contact Points: www.cordis.lu/fp6/lifescihealth
•ERC webpage: http://erc.europa.eu
•The Health Directorate – Director: Dr O. Quintana-Trias:
[email protected]
• TB research: Hannu Lång: [email protected]
• Infectious Diseases unit http://ec.europa.eu/research/health/povertydiseases/index_en.html
• Framework Programme 7: http://cordis.europa.eu/fp7
12